Rare Focus is a brief update designed to help people working in rare diseases keep track of important developments in Europe.
Each edition highlights a small number of points that matter for day-to-day planning - for example:
- what EU JCA and national HTA bodies are signalling
- how expectations for patient input are evolving
- areas where teams may need to prepare earlier
- changes that could influence evidence planning or coordination
The aim is to give teams a clear, straightforward summary they can read in a few minutes, without needing to follow multiple sources.
Rare Focus is relevant for clinical teams, patient-engagement leads, HEOR, market access, medical affairs and anyone supporting rare-disease programmes across Europe or from the US.
If you’d like to receive future editions by email, you can add your details below.
Subscribe to Rare Focus
Receive brief, occasional updates to support readiness as EU JCA and European assessment processes develop.
We’ll only use your details to send Rare Focus and occasional related updates. You can unsubscribe at any time. See our Privacy Policy for how we manage your data.